These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 12637715)
21. Bioterrorism. Vaccines for biodefense: a system in distress. Cohen J; Marshall E Science; 2001 Oct; 294(5542):498-501. PubMed ID: 11641476 [No Abstract] [Full Text] [Related]
22. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090 [TBL] [Abstract][Full Text] [Related]
23. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning. Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047 [TBL] [Abstract][Full Text] [Related]
24. The effect of oral pyridostigmine bromide nerve agent prophylaxis on return of twitch height in persons receiving succinylcholine. Pellegrini JE; Baker AB; Fontenot DJ; Cardenas AF Mil Med; 2000 Apr; 165(4):252-5. PubMed ID: 10802993 [TBL] [Abstract][Full Text] [Related]
26. The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process. Roden DM; Temple R Circulation; 2005 Apr; 111(13):1697-702. PubMed ID: 15811869 [No Abstract] [Full Text] [Related]
27. The controversial anthrax vaccine. Goldstein R Nurs Spectr (Wash D C); 1999 Jun; 9(11):20-1. PubMed ID: 10562219 [No Abstract] [Full Text] [Related]
28. How are drugs approved? Part 3. The stages of drug development. Howland RH J Psychosoc Nurs Ment Health Serv; 2008 Mar; 46(3):17-20. PubMed ID: 18416270 [TBL] [Abstract][Full Text] [Related]
29. Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets. Stevens D; Scott EA; Bowditch AP; Griffiths GD; Pearce PC Pharmacol Biochem Behav; 2006 Jun; 84(2):207-18. PubMed ID: 16806443 [TBL] [Abstract][Full Text] [Related]
30. CancerScope: FDA Advisory Committee supports second HPV vaccine. Printz C Cancer; 2009 Nov; 115(22):5130. PubMed ID: 19890873 [No Abstract] [Full Text] [Related]
31. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning. Berend S; Vrdoljak AL; Radić B; Kuca K Chem Biol Interact; 2008 Sep; 175(1-3):413-6. PubMed ID: 18547553 [TBL] [Abstract][Full Text] [Related]
32. Multiple vaccine and pyridostigmine interactions: effects on EEG and sleep in the common marmoset. Williams KE; Mann TM; Chamberlain S; Smith A; Wilson S; Griffiths GD; Bowditch AP; Scott EA; Pearce PC Pharmacol Biochem Behav; 2006 Jun; 84(2):282-93. PubMed ID: 16828151 [TBL] [Abstract][Full Text] [Related]
33. Latency and exposure-health associations in Gulf War veterans with early fatigue onsets: a case-control study. Lucas KE; Rowe PC; Armenian HK Ann Epidemiol; 2007 Oct; 17(10):799-806. PubMed ID: 17662618 [TBL] [Abstract][Full Text] [Related]
34. Justiciability--waiving for the flag: should informed consent rules apply in the context of military emergencies? Seftel SB George Washington Law Rev; 1992 Jun; 60(5):1387-435. PubMed ID: 16086522 [No Abstract] [Full Text] [Related]
36. Pyridostigmine in the treatment of orthostatic intolerance. Gales BJ; Gales MA Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509 [TBL] [Abstract][Full Text] [Related]
37. Development of vaccines for bio-warfare agents. Rosenthal SR; Clifford JC Dev Biol (Basel); 2002; 110():99-105. PubMed ID: 12477312 [TBL] [Abstract][Full Text] [Related]
38. Preventive vaccines against bioterrorism: evaluation of efficacy and safety. Horne AD; Clifford J; Goldenthal KL; Kleppinger C; Lachenbruch PA Vaccine; 2004 Nov; 23(1):84-90. PubMed ID: 15519711 [TBL] [Abstract][Full Text] [Related]
39. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process. Binzak BA Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592 [No Abstract] [Full Text] [Related]
40. How vaccines are developed. Douglas RG Curr Clin Top Infect Dis; 1994; 14():192-204. PubMed ID: 8086115 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]